×
ADVERTISEMENT
ADVERTISEMENT

Glenmark Pharma gets USFDA nod for central nervous system stimulant drug

Glenmark's current portfolio consists of 168 products authorised for distribution in the US marketplace and 43 ANDA's pending approval with the USFDA
Last Updated : 28 January 2021, 07:20 IST
ADVERTISEMENT

Follow Us :

Comments
ADVERTISEMENT
Published 28 January 2021, 06:11 IST

Follow us on :

Follow Us